PDCD1 and cancer: Another study highlights PD-1 as a tumor suppressor that restricts glycolysis and AP-1 activity in T cell lymphomas, suggesting that metabolic reprogramming contributes to T cell dysfunction and could influence the interpretation of Tex markers across cancers, aligning with the study of HIF-pathway [42].